⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OPK News
Opko Health Inc.
Form 8-K
sec.gov
OPK
OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
globenewswire.com
OPK
OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
globenewswire.com
OPK
Cellular Health Screening Market Size to Reach USD 10.65 Billion by 2035 | SNS Insider
globenewswire.com
DGX
LH
OPK
Form 8-K
sec.gov
OPK
Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026
globenewswire.com
ENTX
OPK
Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026
globenewswire.com
OPK
Starting Tomorrow! C-Level Technology Leadership and the Rise of Iconic Leaders Will Shape the Conversation at HMG Strategy’s 2026 New York CISO Summit. Be a Part of It. Register Now.
globenewswire.com
MSFT
PFE
BAC
CVS
FMS
OPK
VERA
CMCSA
LH
Tetraspecific Antibodies Clinical Pipeline Market research 2026: Development Technologies, Therapeutic Approaches & Market Opportunity Insight to 2032
globenewswire.com
OPK
IPHA
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
globenewswire.com
OPK